Icon Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Buy |
755
+170
| +29% | +$89.3K | 0.03% | 278 |
|
|
2025
Q1 | $371K | Buy |
585
+180
| +44% | +$114K | 0.03% | 258 |
|
|
2024
Q4 | $288K | Sell |
405
-9
| -2% | -$6.41K | 0.02% | 305 |
|
|
2024
Q3 | $435K | Buy |
414
+2
| +0.5% | +$2.1K | 0.04% | 228 |
|
|
2024
Q2 | $445K | Sell |
412
-116
| -22% | -$125K | 0.04% | 224 |
|
|
2024
Q1 | $508K | Buy |
528
+35
| +7% | +$33.7K | 0.05% | 208 |
|
|
2023
Q4 | $433K | Buy |
+493
| New | +$433K | 0.05% | 212 |
|
|
2022
Q4 | $247K | Sell |
342
-43
| -11% | -$31K | 0.03% | 281 |
|
|
2022
Q3 | $265K | Buy |
+385
| New | +$265K | 0.03% | 260 |
|